BRPI0621148A2 - polipeptìdeo purificado, moléculas de ácido nucléico isolada, célula isolada, método para produzir um polipeptìdeo, composição, métodos para inibir o crescimento microbiano, artigo manufaturado e anticorpo purificado - Google Patents

polipeptìdeo purificado, moléculas de ácido nucléico isolada, célula isolada, método para produzir um polipeptìdeo, composição, métodos para inibir o crescimento microbiano, artigo manufaturado e anticorpo purificado Download PDF

Info

Publication number
BRPI0621148A2
BRPI0621148A2 BRPI0621148-8A BRPI0621148A BRPI0621148A2 BR PI0621148 A2 BRPI0621148 A2 BR PI0621148A2 BR PI0621148 A BRPI0621148 A BR PI0621148A BR PI0621148 A2 BRPI0621148 A2 BR PI0621148A2
Authority
BR
Brazil
Prior art keywords
polypeptide
variant
seq
fragment
nucleic acid
Prior art date
Application number
BRPI0621148-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Tonatiuh Melgarejo
Frank Blecha
Yongming Sang
Maria Teresa Ortega
Original Assignee
Univ Kansas State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas State filed Critical Univ Kansas State
Publication of BRPI0621148A2 publication Critical patent/BRPI0621148A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0621148-8A 2005-12-29 2006-12-29 polipeptìdeo purificado, moléculas de ácido nucléico isolada, célula isolada, método para produzir um polipeptìdeo, composição, métodos para inibir o crescimento microbiano, artigo manufaturado e anticorpo purificado BRPI0621148A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
US60/754,878 2005-12-29
PCT/US2006/049637 WO2007076162A2 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Publications (1)

Publication Number Publication Date
BRPI0621148A2 true BRPI0621148A2 (pt) 2011-11-29

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0621148-8A BRPI0621148A2 (pt) 2005-12-29 2006-12-29 polipeptìdeo purificado, moléculas de ácido nucléico isolada, célula isolada, método para produzir um polipeptìdeo, composição, métodos para inibir o crescimento microbiano, artigo manufaturado e anticorpo purificado

Country Status (8)

Country Link
US (1) US7985832B2 (https=)
EP (1) EP1966235A4 (https=)
JP (1) JP2009521932A (https=)
CN (1) CN101351474A (https=)
AU (1) AU2006330769A1 (https=)
BR (1) BRPI0621148A2 (https=)
CA (1) CA2632782A1 (https=)
WO (1) WO2007076162A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521932A (ja) 2005-12-29 2009-06-11 カンザス ステート ユニバーシティー リサーチ ファウンデーション 抗菌性カテリシジンペプチド
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
JP2010515685A (ja) 2007-01-08 2010-05-13 アンドロサイエンス コーポレーション (置換フェニル)−プロペナール部分を伴う化合物、その誘導体、生物学的活性およびその使用
CN101820765A (zh) * 2007-07-31 2010-09-01 安德鲁科技有限公司 包含雄激素受体降解(ard)增强剂的组合物和预防性或治疗性治疗皮肤病与脱发的方法
KR20100057640A (ko) * 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 인슐린 c-펩티드 단독 또는 glp-1과의 배합물의 용도
WO2009043440A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
US20120149631A1 (en) * 2009-06-16 2012-06-14 George Mason Intellectual Properties, Inc Antimicrobial and antibiofilm activity of cathelicidins
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
AU2012332014B2 (en) 2011-10-31 2017-01-19 Kane Biotech Inc. Compositions and methods for preventing and treating oral diseases
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
MX2016010864A (es) 2014-02-21 2017-05-08 Avadim Tech Inc Metodo para el mantenimiento de cateteres uretrales.
JP2017519035A (ja) * 2014-06-27 2017-07-13 ケーン バイオテク インコーポレーテッド 抗微生物性−抗バイオフィルム性組成物及び該組成物のパーソナルケア製品のための使用
EP3244907B1 (en) 2015-01-13 2020-02-19 City of Hope Ctla4-binding protein peptide-linker masks
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
EP3541424A4 (en) * 2016-11-15 2020-10-28 The Rockefeller University CHEMERICAL ANTIBODIES INCLUDING BINDING DOMAINS OF PHAGE LYSINES, BACTERIAL AUTOLYSINS, BACTERIOCINS, AND PHAGE TAIL OR PHAGE TAIL FIBRILLES
WO2018094403A1 (en) * 2016-11-21 2018-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Novel antimicrobial and anti-cancer therapy
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
WO2005040192A2 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) * 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
JP2009521932A (ja) * 2005-12-29 2009-06-11 カンザス ステート ユニバーシティー リサーチ ファウンデーション 抗菌性カテリシジンペプチド
JP2010533705A (ja) * 2007-07-15 2010-10-28 ヒルマン,イチャク 抗菌ペプチドまたはその阻害剤を用いた疾病治療

Also Published As

Publication number Publication date
US7985832B2 (en) 2011-07-26
AU2006330769A1 (en) 2007-07-05
US20090221483A1 (en) 2009-09-03
CA2632782A1 (en) 2007-07-05
EP1966235A4 (en) 2010-01-06
EP1966235A2 (en) 2008-09-10
WO2007076162A3 (en) 2008-09-12
JP2009521932A (ja) 2009-06-11
CN101351474A (zh) 2009-01-21
WO2007076162A2 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
BRPI0621148A2 (pt) polipeptìdeo purificado, moléculas de ácido nucléico isolada, célula isolada, método para produzir um polipeptìdeo, composição, métodos para inibir o crescimento microbiano, artigo manufaturado e anticorpo purificado
García et al. Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity
Wu et al. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332
TW200950800A (en) Use of defensins against tuberculosis
EP0375724A1 (en) BIOLOGICALLY ACTIVE BACTERICIDAL / PERMEABILITY-ENHANCING PROTEIN FRAGMENTS.
WO2005040201A1 (en) Human cathelicidin antimicrobial peptides
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
Pepperney et al. Antibacterial peptides: opportunities for the prevention and treatment of dental caries
CA2776883A1 (en) Antimicrobial and antibiofilm activity of cathelicidins
IL127319A (en) Formations of lactoprene and their uses
Won et al. Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide
JP2011503137A (ja) 新規のアルギニン置換ペプチド及びその使用
Si et al. Soluble expression of active human β-defensin-3 inEscherichia coliand its effects on the growth of host cells
WO2006084463A1 (en) Systemic treatment of infections with defensins
CN102264383A (zh) 胞内细菌感染的处理
US20090253629A1 (en) Use of defensins against meningitis
US8653024B2 (en) Use of AMPs for treatment of UTI/cystitis
WO2003087143A2 (en) Human polypeptides having antibacterial activity
Bao NGC-HLB, a novel antimicrobial peptide from the skin secretion of Hylarana latouchii
against Food-Borne the Chicken Digestive Tract and Has
WO2011067335A1 (en) Use of defensins for treatment of infective endocarditis

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.